RhumbLine Advisers
NARI

RhumbLine Advisers’s Inari Medical, Inc. Common Stock NARI Stock Holding History

RhumbLine Advisers’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-140,869
Closed -$7.19M – 4170
2024
Q4 		$7.19M Sell
140,869
-4,356
-3% -$214K 0.01% 1227
2024
Q3 		$5.99M Sell
145,225
-4,858
-3% -$233K 0.01% 1332
2024
Q2 		$7.23M Sell
150,083
-1,038
-0.7% -$46K 0.01% 1188
2024
Q1 		$7.25M Sell
151,121
-11,741
-7% -$627K 0.01% 1215
2023
Q4 		$10.6M Sell
162,862
-1,734
-1% -$104K 0.01% 1029
2023
Q3 		$10.8M Buy
164,596
+2,344
+1% +$147K 0.01% 951
2023
Q2 		$9.43M Buy
162,252
+9,327
+6% +$588K 0.01% 1038
2023
Q1 		$9.44M Sell
152,925
-521
-0.3% -$31.3K 0.01% 987
2022
Q4 		$9.75M Buy
153,446
+4,979
+3% +$361K 0.01% 954
2022
Q3 		$10.8M Buy
148,467
+29,865
+25% +$2.22M 0.02% 853
2022
Q2 		$8.06M Buy
118,602
+82,605
+229% +$5.94M 0.01% 1005
2022
Q1 		$3.26M Buy
35,997
+1,005
+3% +$82.3K ﹤0.01% 1563
2021
Q4 		$3.19M Sell
34,992
-430
-1% -$36.9K ﹤0.01% 1617
2021
Q3 		$2.87M Buy
35,422
+1,317
+4% +$111K ﹤0.01% 1685
2021
Q2 		$3.18M Buy
34,105
+15,246
+81% +$1.48M ﹤0.01% 1693
2021
Q1 		$2.02M Buy
18,859
+8,613
+84% +$894K ﹤0.01% 1908
2020
Q4 		$894K Buy
10,246
+2,214
+28% +$156K ﹤0.01% 2188
2020
Q3 		$554K Buy
+8,032
New +$516K ﹤0.01% 2242

Other funds holding NARI

SA
SoundView Advisors Olympia, Washington $281M AUM 17.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return

RhumbLine Advisers's NARI Position: Q1 2025 in Review

RhumbLine Advisers sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 140,869 shares — an estimated $7.19M sold.

RhumbLine Advisers first reported a position in NARI in Q3 2020 and held it in 18 quarters. The position peaked at $10.8M in Q3 2022. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • RhumbLine Advisers reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • RhumbLine Advisers sold 140,869 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $7.19M.
  • RhumbLine Advisers first reported a position in Inari Medical, Inc. Common Stock in Q3 2020 and held it in 18 quarters.
  • RhumbLine Advisers's Inari Medical, Inc. Common Stock position peaked at $10.8M in Q3 2022.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on RhumbLine Advisers's 13F filing for Q1 2025, filed 8 Apr 2025.